MIMED2024: Motor Imagery MIMED dataset from Wirawan et al. 2024
…Emotiv EPOC X Reference: CMS/DRL (P3/P4) Ground: DRL Sensor type…
- Participants
- 30
- Size
- 41.2 MB
- Version
- vv1.0.0
- Updated
- Oct 8, 2026
100 results for "Emotiv EPOC X" · page 1 of 10 · ranked by relevance
…Emotiv EPOC X Reference: CMS/DRL (P3/P4) Ground: DRL Sensor type…
[ Sensor type…
EmoEEG-MC is a multi-context emotional EEG dataset containing 64-channel EEG and peripheral physiological signals (PPG and GSR) from 60 participants. Emotions were induced in two contexts, video viewing and mental imagery, and covered seven categories: joy, inspiration, tenderness, fear, disgust, sadness and neutral. The dataset is intended to support cross-context emotion decoding, and SVM baselines with L1 regularization achieved above-chance accuracy for binary and seven-category classification.
…Released as recorded (EPOC X hardware bandpass only; no additional software filtering…
Resting-state EEG recorded from 25 patients with Parkinson's disease in a double-blind, randomized, placebo-controlled trial of Neuroepo, an EPO formulation with low sialic acid content. Recordings were acquired before and six months after drug administration, in Neuroepo (n=15) and placebo (n=10) groups. The raw data are shared in EEG-BIDS format to support evaluation of EEG biomarkers of neuroprotection, including qualitative expert ratings and quantitative source-level analysis.
Multisession EEG and clinical dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (an erythropoietin formulation) in patients with Parkinson's disease. Participants were assessed at baseline and 9 months after the intervention, with cumulative NeuroEPO dose quantified and placebo coded as zero. The dataset supports analysis of treatment exposure, EEG-derived measures, and motor outcomes (MDS-UPDRS III).
…Data were collected using a 14-channel EMOTIV EPOC X headset.
Multisession EEG dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (erythropoietin-derived formulation) in patients with Parkinson's disease. Clinical (MDS-UPDRS III) and EEG assessments were acquired at baseline and 9 months after completing the intervention. Cumulative NeuroEPO dose is coded per participant (placebo = 0), enabling analysis of treatment effects on brain activity.
…Only the 32 EEG channels are retained; EMOTIV metadata channels (timestamps, counters…